Dengue fever in the Americas

Hinh Ly
DOI: https://doi.org/10.1080/21505594.2024.2375551
IF: 5.428
2024-07-13
Virulence
Abstract:KEYWORDS: Dengue virus (DENV) is the causative agent of dengue fever [ Citation 1 , Citation 2 ]. Dengue fever cases have increased significantly worldwide within the last two decades. A recent estimate indicates that as many as 390 million DENV infections occur each year, and that many infected individuals are asymptomatic or subclinical [ Citation 3 ]. Only about one in four persons infected the first time develop symptoms, such as fever, headaches, fatigue, nausea, vomiting, a skin rash that looks like measles, and/or extremely painful body aches (and hence it's sometimes being referred to as break-bone fever). Most inflicted people recover in 1–2 weeks, but about 1 in 20 people can develop more severe forms of the disease known as dengue hemorrhagic fever and dengue shock syndrome that can be fatal. The more times a person is infected with DENV, the higher the risk they are for severe and lethal complications. Dengue hemorrhagic fever has the highest case numbers of all known viral hemorrhagic fevers in the world, surpassing Ebola and Lassa fever cases, for example. As with all known viral hemorrhagic fever diseases, there is currently no specific drug to treat dengue fever, and supportive care (e.g. providing rest and fluids and acetaminophen as pain and fever reducer) is the only remedy.
microbiology,immunology,infectious diseases
What problem does this paper attempt to address?